Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
Actual shortage: | 11 (2%) | |
Anticipated shortage: | 1 (0%) | |
Avoided shortage: | 85 (13%) | |
Resolved: | 546 (85%) | |
Discontinuation Reports |
234 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 234 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
81 (9%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-ACYCLOVIR | 200MG | TABLET | Resolved | 2023-02-01 | 2023-03-20 | 182969 |
MYLAN-ACYCLOVIR | 800MG | TABLET | Avoided shortage | 2023-03-20 | 2023-04-20 | 187554 |
MYLAN-ACEBUTOLOL (TYPE S) | 200MG | TABLET | Avoided shortage | 2017-04-07 | 2017-08-24 | 5922 |
MYLAN-ACEBUTOLOL (TYPE S) | 400MG | TABLET | Resolved | 2017-04-07 | 2017-11-02 | 5962 |
MYLAN-ACEBUTOLOL (TYPE S) | 100MG | TABLET | Resolved | 2017-04-07 | 2018-02-02 | 5987 |
MYLAN-ACEBUTOLOL | 100MG | TABLET | Resolved | 2017-04-07 | 2018-07-04 | 5941 |
MYLAN-ACEBUTOLOL | 200MG | TABLET | Resolved | 2017-11-23 | 2018-07-04 | 30377 |
MYLAN-ACEBUTOLOL | 400MG | TABLET | Resolved | 2018-01-15 | 2018-07-04 | 35919 |
MYLAN-ABACAVIR/LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2018-10-23 | 2019-02-16 | 65420 |
MYLAN-ABACAVIR/LAMIVUDINE | 600MG 300MG | TABLET | Avoided shortage | 2019-04-10 | 2019-05-28 | 81021 |
MYLAN-ABACAVIR/LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-05-28 | 2019-06-19 | 85021 |
MYL-SILDENAFIL | 50MG | TABLET | Resolved | 2017-04-04 | 2018-08-23 | 5307 |
MYL-SILDENAFIL | 25MG | TABLET | Resolved | 2017-04-07 | 2017-10-03 | 5931 |
MYL-SILDENAFIL | 100MG | TABLET | Avoided shortage | 2017-04-13 | 2017-07-17 | 6976 |
MYL-PROPAFENONE | 150MG | TABLET | Resolved | 2017-09-22 | 2018-03-02 | 23160 |
MYL-PROPAFENONE | 300MG | TABLET | Resolved | 2017-09-22 | 2018-03-02 | 23163 |
MYL-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-01-06 | 2021-02-04 | 130906 |
MOVISSE | 0.35MG | TABLET | Avoided shortage | 2017-10-18 | 2018-02-09 | 26211 |
MOVISSE | 0.35MG | TABLET | Resolved | 2019-05-14 | 2019-08-31 | 84070 |
MOVISSE | 0.35MG | TABLET | Resolved | 2019-08-07 | 2020-01-23 | 91044 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-ACEBUTOLOL (TYPE S) | 100MG | TABLET | Discontinued | 2017-08-24 | 2018-02-15 | 20275 |
MYLAN-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20309 |
MYLAN-ACEBUTOLOL | 200MG | TABLET | Discontinued | 2017-11-23 | 2018-07-04 | 30374 |
MYLAN-ACEBUTOLOL | 100MG | TABLET | Discontinued | 2018-06-12 | 2018-07-04 | 52262 |
MYL-SILDENAFIL | 100MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16057 |
MYL-SILDENAFIL | 25MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16172 |
MYL-SILDENAFIL | 50MG | TABLET | Discontinued | 2017-07-18 | 2018-05-02 | 16175 |
MYL-PROPAFENONE | 150MG | TABLET | Discontinued | 2018-03-02 | 2018-03-02 | 41530 |
MYL-PROPAFENONE | 300MG | TABLET | Discontinued | 2018-03-02 | 2018-03-02 | 41533 |
GEMCITABINE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6698 |
GEMCITABINE FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6701 |
ESME 28 | 20MCG 100MCG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53722 |
ESME 21 | 20MCG 100MCG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53714 |
AZITHROMYCIN FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-07-17 | 2018-02-15 | 15804 |